GlassScriptPhysician profile
Jenna DO Madsen
NPI 1063851343
$1,256.59
in general payments reported to CMS, 2019-2025
22 companies · $375 in 2025
The $375 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $111 · 2021: $107 · 2022: $216 · 2023: $225 · 2024: $223 · 2025: $375.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $823.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $823.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $191.93 | 2020-2022 | |
| Exeltis, USA INC. | $174.82 | 2022-2025 | Slynd |
| Astellas Pharma US INC | $144.84 | 2020-2024 | Veozah |
| Mayne Pharma Commercial LLC | $101.66 | 2022-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $95.06 | 2021-2025 | |
| Organon LLC | $71.71 | 2023-2025 | Nexplanon |
| Sage Therapeutics, LLC | $63.01 | 2025 | Zurzuvae |
| Davol INC. | $44.02 | 2024 | Arista Ah Flexitip |
| Channel Medsystems, INC. | $40.59 | 2024 | |
| Sumitomo Pharma America, INC. | $39.24 | 2023-2025 | Gemtesa |
| Daiichi Sankyo INC. | $36.61 | 2020-2022 | |
| Therapeuticsmd, INC. | $32.00 | 2020-2021 | |
| Shield Therapeutics INC | $31.38 | 2023-2024 | Accrufer |
| Hologic Sales and Service, LLC | $30.67 | 2024 | Thinprep 2000 Processor |
| Baxter Healthcare | $30.10 | 2025 | Perclot |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $26.59 | 2022-2023 | Paragard T 380a |
| Myovant Sciences INC. | $20.94 | 2022 | |
| Pfizer INC. | $17.92 | 2023 | |
| Ethicon US, LLC | $17.70 | 2025 | Vistaseal, Surgiflo Hemostatic Matrix, Ethicon |
| Merck Sharp & Dohme LLC | $15.35 | 2025 | Gardasil 9 |
| C. R. Bard, INC. & Subsidiaries | $15.29 | 2022 | |
| Supernus Pharmaceuticals, INC. | $15.16 | 2025 | Qelbree |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Madsen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.